- NCIt
- C4858
Loading cancer entity…
Loading cancer entity…
Clinical trials
4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT04562558 | Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | active not recruiting | N/A | 228 | xiang yangOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT06056635 | A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures | recruiting | N/A | 50 | Boston Children's HospitalOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT02892877 | The French National Reference Centre of GTD(French GTDC) | recruiting | — | 25,500 | Hospices Civils de Lyon |
Data updated 23 days agoSource updated Jun 17, 2026source: clinicaltrials
| 1 |
| Sep 8, 2016 |
| clinicaltrials |